Adage Capital Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Buy |
+8,967
| New | +$344K | ﹤0.01% | 821 |
|
|
2024
Q2 | – | Sell |
-1,304,320
| Closed | -$55.9M | – | 899 |
|
|
2024
Q1 | $55.9M | Buy |
1,304,320
+488,280
| +60% | +$20.9M | 0.11% | 207 |
|
|
2023
Q4 | $30.2M | Sell |
816,040
-428,471
| -34% | -$15.9M | 0.06% | 316 |
|
|
2023
Q3 | $45.1M | Buy |
+1,244,511
| New | +$45.1M | 0.1% | 218 |
|
|
2022
Q1 | – | Sell |
-208,000
| Closed | -$11.5M | – | 1103 |
|
|
2021
Q4 | $11.5M | Buy |
+208,000
| New | +$11.5M | 0.02% | 659 |
|
|
2018
Q1 | – | Sell |
-340,000
| Closed | -$15.1M | – | 740 |
|
|
2017
Q4 | $15.1M | Sell |
340,000
-140,000
| -29% | -$6.21M | 0.03% | 493 |
|
|
2017
Q3 | $24.4M | Sell |
480,000
-200,000
| -29% | -$10.2M | 0.06% | 369 |
|
|
2017
Q2 | $36.7M | Sell |
680,000
-280,000
| -29% | -$15.1M | 0.09% | 291 |
|
|
2017
Q1 | $50.6M | Buy |
960,000
+320,000
| +50% | +$16.9M | 0.13% | 222 |
|
|
2016
Q4 | $30.8M | Hold |
640,000
| – | – | 0.08% | 288 |
|
|
2016
Q3 | $34.5M | Hold |
640,000
| – | – | 0.1% | 284 |
|
|
2016
Q2 | $34.7M | Sell |
640,000
-60,000
| -9% | -$3.25M | 0.09% | 258 |
|
|
2016
Q1 | $35.5M | Sell |
700,000
-200,000
| -22% | -$10.1M | 0.1% | 250 |
|
|
2015
Q4 | $45.4M | Sell |
900,000
-140,000
| -13% | -$7.06M | 0.12% | 210 |
|
|
2015
Q3 | $50M | Buy |
+1,040,000
| New | +$50M | 0.14% | 197 |
|
|
2013
Q3 | – | Sell |
-260,000
| Closed | -$16.2M | – | 693 |
|
|
2013
Q2 | $16.2M | Buy |
+260,000
| New | +$16.2M | 0.05% | 408 |
|